Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.46 HKD | +2.76% | +11.78% | +9.05% |
Sales 2023 | 10.53B 1.35B | Sales 2024 * | 12.06B 1.54B | Capitalization | 15.2B 1.94B |
---|---|---|---|---|---|
Net income 2023 | 1.88B 240M | Net income 2024 * | 2.44B 313M | EV / Sales 2023 | 1.37 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.26 x |
P/E ratio 2023 |
7.63
x | P/E ratio 2024 * |
6.29
x | Employees | - |
Yield 2023 |
6.36% | Yield 2024 * |
3% | Free-Float | 28.39% |
Latest transcript on Grand Pharmaceutical Group Limited
1 day | +1.38% | ||
1 week | +10.28% | ||
Current month | +7.06% | ||
1 month | +7.06% | ||
3 months | +29.03% | ||
6 months | +2.09% | ||
Current year | +7.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 34 | 19-03-31 |
Tin Chung Foo
SEC | Corporate Secretary | 56 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 61 | 05-03-20 |
Ye Bi Hu
BRD | Director/Board Member | 60 | 18-12-30 |
Geng Pei
BRD | Director/Board Member | 64 | 11-05-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.86% | 4 M€ | -27.92% | ||
0.01% | 117 M€ | -0.14% | - | |
0.01% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 4.46 | +2.76% | 356 494 |
24-04-30 | 4.34 | -0.23% | 3,930,000 |
24-04-29 | 4.35 | +0.69% | 3,701,000 |
24-04-26 | 4.32 | +1.41% | 5,759,000 |
24-04-25 | 4.26 | +5.19% | 5,492,500 |
Delayed Quote Hong Kong S.E., May 01, 2024 at 11:24 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.58% | 1.94B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- 512 Stock